Business Daily from THE HINDU group of publications
Monday, Nov 02, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Monday, Nov 02, 2009 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Aurobindo Pharma returns to profits with Rs 103-cr net Our Bureau Hyderabad, Nov. 1 Aurobindo Pharma Ltd posted a consolidated net profit of Rs 103 crore in the second quarter ended September 30. The Hyderabad-based company had incurred a loss of Rs 38.5 crore in the corresponding quarter of the previous financial year. The higher earnings were driven by growth in total revenue at Rs 842 crore (Rs 658 crore). Aurobindo lost Rs 3.67 crore due to restatement of foreign currency convertible bonds (net of deposits). During the quarter, Trident Life Sciences Ltd had become a wholly owned subsidiary of Aurobindo by acquisition of shares. Further, it had also entered into an agreement for establishing a 75:25 joint venture for injectable products in the name of Auronex Pharma Ltd. The said company had since become a subsidiary of Aurobindo, the BSE was informed. Pfizer acquires rights to 60 products of Aurobindo Aurobindo Q1 net trebles More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2009, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|